IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA)
CUSIP: 462260100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 415,431,143
- Total 13F shares
- 239,455,648
- Share change
- -1,249,565
- Total reported value
- $797,796,916
- Put/Call ratio
- 118%
- Price per share
- $3.33
- Number of holders
- 292
- Value change
- -$41,501,290
- Number of buys
- 151
- Number of sells
- 142
Quarterly Holders Quick Answers
What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 462260100:
Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wayne P. Rothbaum |
3/4/5
|
Director |
—
mixed-class rows
|
28,167,333
mixed-class rows
|
$257,731,097 | — | 01 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
27,534,340
|
$203,754,116 | — | 31 Dec 2024 | |
| MHR FUND MANAGEMENT LLC |
13F
|
Company |
5.9%
|
24,417,103
|
$180,686,562 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.7%
|
23,476,035
|
$173,722,660 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
|
Company |
3.8%
from 13D/G
|
22,112,266
|
$163,630,768 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
12,249,282
|
$90,644,687 | — | 31 Dec 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
2.2%
|
8,991,573
|
$66,537,640 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.6%
|
6,560,000
|
$48,544,000 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
5,871,420
|
$43,457,717 | — | 31 Dec 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.4%
|
5,834,456
|
$43,175,000 | — | 31 Dec 2024 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
1.2%
|
5,132,000
|
$37,976,800 | — | 31 Dec 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.1%
|
4,750,934
|
$35,157,000 | — | 31 Dec 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.1%
|
4,542,168
|
$33,612,043 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.99%
|
4,110,056
|
$30,414,413 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.95%
|
3,959,839
|
$29,302,812 | — | 31 Dec 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.88%
|
3,646,787
|
$26,985,555 | — | 31 Dec 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.84%
|
3,500,000
|
$25,900,000 | — | 31 Dec 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.73%
|
3,041,685
|
$22,508,469 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.68%
|
2,819,799
|
$20,866,513 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.65%
|
2,704,469
|
$20,013,070 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.64%
|
2,673,905
|
$19,786,897 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.64%
|
2,662,695
|
$19,703,943 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.63%
|
2,628,101
|
$19,449,000 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.58%
|
2,430,221
|
$17,979,182 | — | 31 Dec 2024 | |
| Man Group plc |
13F
|
Company |
0.58%
|
2,414,996
|
$17,870,970 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
2,414,807
|
$17,869,572 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
1,989,340
|
$14,721,116 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.46%
|
1,907,727
|
$14,117,180 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.42%
|
1,746,877
|
$12,926,890 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.41%
|
1,696,301
|
$12,552,627 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.41%
|
1,683,208
|
$12,455,739 | — | 31 Dec 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.38%
|
1,594,532
|
$11,799,540 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.38%
|
1,563,296
|
$11,568,390 | — | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.34%
|
1,416,014
|
$10,478,503 | — | 31 Dec 2024 | |
| APIS CAPITAL ADVISORS, LLC |
13F
|
Company |
0.33%
|
1,363,000
|
$10,086,200 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
1,306,826
|
$9,670,512 | — | 31 Dec 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.3%
|
1,260,000
|
$9,324,000 | — | 31 Dec 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.3%
|
1,235,448
|
$9,142,315 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
1,130,455
|
$8,365,367 | — | 31 Dec 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.27%
|
1,121,417
|
$8,298,486 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.27%
|
1,106,040
|
$8,184,696 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
1,093,604
|
$8,092,670 | — | 31 Dec 2024 | |
| Orion Investment Co |
13F
|
Company |
0.26%
|
1,060,755
|
$7,849,587 | — | 31 Dec 2024 | |
| B Group, Inc. |
13F
|
Company |
0.24%
|
992,000
|
$7,340,800 | — | 31 Dec 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.23%
|
949,401
|
$7,025,567 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
867,576
|
$6,420,062 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
865,834
|
$6,407,172 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.2%
|
831,059
|
$6,149,837 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.18%
|
765,399
|
$5,663,953 | — | 31 Dec 2024 | |
| Merrill A. Mcpeak |
3/4/5
|
Director |
—
mixed-class rows
|
618,783
mixed-class rows
|
$5,661,865 | — | 01 Mar 2024 |
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) as of Q1 2025
As of 31 Mar 2025,
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
239,455,648 shares.
The largest 10 holders included
VANGUARD GROUP INC, MHR FUND MANAGEMENT LLC, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, STATE STREET CORP, Long Focus Capital Management, LLC, Hood River Capital Management LLC, Soleus Capital Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
293
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
294
Q1 2025 holders
292
Holder diff
-2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.